Anika Therapeutics, Inc. ANIK
13.62 USD +0.77 (+5.99%)
Regular-session close
13.62 0.00 0.00%
After hours · Nov 18, 4:01 PM ET
12.76 Day range 13.84
9.01 52-week range 22.88
- YTD
- +41.73%
- 1 year
- +40.85%
News
benzinga.com B. Riley Securities Reiterates Buy on Anika Therapeutics, Lowers Price Target to $17 B. Riley Securities analyst Madison El-Saadi reiterates Anika Therapeutics (NASDAQ:ANIK) with a Buy and lowers the price target from $23 to $17.
benzinga.com Anika Therapeutics Q3 2026 Earnings Call Transcript Anika Therapeutics (NASDAQ:ANIK) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Anika Therapeutics Raises FY2026 Sales Guidance from $118.460M-$124.101M to $119.588M-$124.101M vs $121.639M Est Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $118.460 million-$124.101 million to $119.588 million-$124.101 million vs $121.639 million estimate.
benzinga.com Anika Therapeutics Q3 Adj. EPS $0.29 Beats $0.06 Estimate, Sales $30.594M Beat $29.436M Estimate Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.06 by 383.33 percent. This is a 625 percent increase over earnings of…
